Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / DNLI - Denali: Leveraging Transport Vehicle Technology For Neurological Gains

DNLI - Denali: Leveraging Transport Vehicle Technology For Neurological Gains

Denali Therapeutics Inc.

2024-03-06 22:05:07 ET

Summary

  • Denali's stock performance has been flat despite the biotech sector's 20% rise; recently raised $500 million in a PIPE.
  • ALS trial failure with partner Sanofi pressured stock; Denali's focus is on transport vehicle (TV) technology and BBB crossing.
  • Denali boasts a strong financial position with $1.53 billion in cash, extending operational runway significantly.
  • Recommends "buy" based on Denali's innovative TV technology, financial health, and potential in neurological disorders despite biotech risks.

Strategic Shifts and Scientific Strides: Analyzing Denali's Latest Moves

Shares of Denali Therapeutics ( DNLI ) have been flat since my last update in October....

For further details see:

Denali: Leveraging Transport Vehicle Technology For Neurological Gains
Stock Information
Company Name: Denali Therapeutics Inc.
Stock Symbol: DNLI
Market: NASDAQ
Website: denalitherapeutics.com
Menu
DNLI DNLI Quote DNLI Short DNLI News DNLI Articles DNLI Message Board
Get DNLI Alerts

News, Short Squeeze, Breakout and More Instantly...